Mineralys Therapeutics, Inc.

MLYS·NASDAQ·$29.99Share Price as of 11/2·$2BMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/11/26 10-QQ1 ended 03/31/2605/06/26 10-KFY 202503/12/26 10-QQ3 ended 09/30/2511/10/25 10-QQ2 ended 06/30/2508/12/25

Disclosures

8-KCurrent report10/29/26 8-KCurrent report10/19/26 8-KCurrent report08/11/26 8-KCurrent report06/03/26 8-KCurrent report06/03/26

Prospectuses and Registrations

424B5Prospectus supplement06/03/26 S-8Registration of securities for employees02/13/26 S-3ASRAutomatic shelf registration11/10/25 424B5Prospectus supplement09/03/25 424B5Prospectus supplement09/02/25

Proxies

DEF 14ADefinitive proxy04/08/26 DEFA14AAdditional proxy materials04/08/26 DEF 14ADefinitive proxy04/09/25 DEFA14AAdditional proxy materials04/09/25 DEF 14ADefinitive proxy04/09/24

Ownership

Form 3Initial insider ownership10/20/26 Form 3Initial insider ownership10/20/26 Form 4Insider transaction10/20/26 Form 4Insider transaction10/20/26 144Proposed sale of securities10/13/26

Other

ARSAnnual report to shareholders04/10/26 ARSAnnual report to shareholders04/09/25 EFFECTRequest for effectiveness04/11/24 ARSAnnual report to shareholders04/09/24 CORRESPCorrespondence with the SEC04/09/24